# Wipro Limited – FDA Inspection, Jun 6, 2025

Source: https://www.keypedia.com/records/fda_inspections/wipro-limited/fc89a307-2a1f-49e9-ae8e-04b124df6f7b
Source feed: FDA_Inspections

> FDA inspection 1275200 of Wipro Limited, June 06, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1275200
- Company Name: Wipro Limited
- Inspection Date: 2025-06-06
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jose-m-cayuela/3ee89bb5-4bba-493b-816f-31b8a9768025)

Company: https://www.keypedia.com/companies/wipro-limited/0fd16641-8e77-4285-b734-65cabc92404d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c